Platelet Rich Plasma Market Synopsis

Platelet Rich Plasma Market Size is Valued at USD 389.10 Million in 2023, and is Projected to Reach USD 1411.14 Million by 2032, Growing at a CAGR of 10.04% From 2024-2032.

PRP market means the market for growth and use of Platelet Rich Plasma, a portion of the patients auto logarithmic platelets. PRP is used in many fields in medicine for example orthopedics, derma and dentists for its reconstructive abilities. The treatment is based on the process of activating the body’s inherent capacities to cure a set of diseases, including chronic arthritis, proper skin care, etc. These industries include tools and kits, centrifuges, kits, and reagents used in PRP preparation and delivery system for minimally invasive procedures as well as personalized medicine.

• The Platelet Rich Plasma market has been exhibiting significant growth trends in a recent past and this growth has come due to the development of the regenerative medicine technology and the demand for noninvasive procedures. PRP therapy is progressively getting popularity among healthcare experts and people that are in the process of treatment because they have to deal with enhanced healing processes and methods aimed on tissue regeneration. However, the orthopedic segment has emerged to be a key market for PRP, mainly because it is applied to treat extremity injuries, arthritis and post-surgery. Also, additional uses of PRP for cosmetic and aesthetic processes, such as face and hair restoration, are opening new segments of the market for the service.
• The intense R&D and increase in automated PRP preparation systems are primary drivers that have fuelled market expansion by augmenting the safety of PRP preparation techniques. Also, new clinical evidence of the effectiveness of PRP therapies is promoting attitudes to accept the innovations among health care professionals and individuals. Another factor, wanting more effective treatments, wants an increase in sports-related injuries as well as a population that is growing older with more desire for non-surgical treatments. With more and more people embracing the use of PRP and the knowledge of its associated benefits, the market is set to rise in the next years.

Platelet Rich Plasma Market Trend Analysis

Increasing Adoption in Aesthetic Procedures

• The growth of specialty clinics and the growing interest in the aesthetic applications of PRP is one of the key trends existent in the Platelet Rich Plasma markets. Since patients are not comfortable with surgeries that involve cutting the face, PRP has come through as a solution to face lift, skin tightening and even hair regrowth. Many clinics and dermatology companies are adding PRP to their menu of treatments because it can enhance skin texture, fine lines and hair growth . The trend is evident from the positive patient outcomes and increased media coverage of the benefits of PRP that has made the process a top-notch procedure for people who would wish to gain improved looks without many scheduled visits to the hospital. Moreover, social networks are actively contributing to the popularity of PRP treatments, patients who are happy with the results shown in their photos are interesting, increase the desire for such operations.

Expanding Applications in Sports Medicine

• The diversification of uses of PRP specifically in sports medicine serves as the one of the best opportunities for the growth of this market. Sporting people and other physically active people are susceptible to musculoskeletal injuries hence need proper treatment methods to ensure short recovery period. PRP therapy is therefore a better solution since healing is faster and recovery time shorter than with other conventional methods. This has prompted manufacturers of PRP to engage sports clinics in developing treatment profiles that apply to athletes. In the same vein, as more sports physicians and trainers prescribe to the use of PRP, there will be further increased usage in the future. Since the sports industry is quickly embracing the use of new therapy methods to boost athletes’ performance and reduce time out of action, the growth of PRP markets is anticipated.

Platelet Rich Plasma Market Segment Analysis:

Platelet Rich Plasma Market Segmented on the basis of type, Origin Type and end user.

By Type, pure-platelet-rich plasma (P-PRP) segment is expected to dominate the market during the forecast period

• The Platelet Rich Plasma market is expected to expand at a steady rate throughout the forecast timeframe due to the effectiveness of various segments such as pure-platelet-rich plasma (P-PRP) owing to its better therapeutic profile than PRP. P-PRP contains a high proportion of platelets and a low amount of red blood cells is ideal for the healing and the formation of new tissues. This particular formulation is more directed at where it needs to be for better patient results in different areas such as orthopedics, derma and cosmetic enhancements.
• With more and more clinical research evidencing the positive outcomes of P-PRP the practitioners tend to incorporate this particular formulation into their practice, subsequently stimulating the demand. Also, the increasing knowledge of the patients concerning the outcome of P-PRP with regard to chronic pain, hair loss, and skin aging, and other associated diseases significantly fuels its market share. In this regard, the segment strategy of enhancing the healing processes makes P-PRP as a top favorite in the global market of Platelet Rich Plasma.

By Origin Type, autologous segment expected to held the largest share

• The technetium autologous segment of the Platelet Rich Plasma market is anticipated to dominate the market share during the forecast period because of the inherent benefits of this segment. e, it is entirely made out of the patient blood thus has better security to bring about allergic reactions or disease transmission than any other allogenic or synthetic products. This aspect of autologous PRP has made it to be embraced by both the medical practitioners and patients because it meets the modern trends in as far as personalised and bio compatible treatments are concerned.
• Further, the autologous segment is implemented in different medico applications such as orthopaedics, plaesthetics, and wound healing mechanisms by exploiting the inherent self-healing-inducing mechanisms of the patients’ own platelets. This segment has excellent future potential as people find out about autologous PRP’s benefits, as well as the progress that extraction and preparation procedures are making, thus maintaining its leadership in the market.

Platelet Rich Plasma Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• According to estimations made for 2023, North America will remain the largest consumer of Platelet Rich Plasma, taking 45% of the global market. This dominance has been explained by factors such as an enhanced presence of the health care facilities, high susceptibility to chronic illnesses, and improving willingness to undergo complex regenerative medicine procedures. The United States leads the way in PRP therapy because of qualitative concentration on research, eruption in demand and positive reimbursement policies for attaining better healing solutions. Also, the essential presence of key market players instrumental to PRP treatment extensions and growth in the cosmetic industry in the region has led to an increased number of aesthetic clinics in the region to contribute to the small but dense market share in this region. The market for PRP is expected to remain consolidated, with number of key players continued to dominate healthcare industry in North America where healthcare providers is still increasing its usage of PRP further expanding its applications across numerous therapeutic indications.

Active Key Players in the Platelet Rich Plasma Market

• Aesthetics Biomedical, Inc. (USA)
• Arthrex, Inc. (USA)
• Celleration, Inc. (USA)
• Celltex Therapeutics (USA)
• Cytomedix, Inc. (USA)
• Emcyte Corporation (USA)
• Harvest Technologies (USA)
• Hyaluronic Acid Co., Ltd. (South Korea)
• KGen Biopharma (South Korea)
• Phoenix Biotechnology, Inc. (USA)
• PLASMAGE (USA)
• Regen Lab (Switzerland)
• Regenerative Medical Solutions, Inc. (USA)
• Suneva Medical, Inc. (USA)
• Terumo BCT, Inc. (USA)
• Other key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Platelet Rich Plasma Market by Type
 4.1 Platelet Rich Plasma Market Snapshot and Growth Engine
 4.2 Platelet Rich Plasma Market Overview
 4.3 pure-platelet-rich plasma (P-PRP)
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 pure-platelet-rich plasma (P-PRP): Geographic Segmentation Analysis
 4.4 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF)
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF): Geographic Segmentation Analysis

Chapter 5: Platelet Rich Plasma Market by Origin Type
 5.1 Platelet Rich Plasma Market Snapshot and Growth Engine
 5.2 Platelet Rich Plasma Market Overview
 5.3 autologous
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 autologous: Geographic Segmentation Analysis
 5.4 homologous and allogenic
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 homologous and allogenic: Geographic Segmentation Analysis

Chapter 6: Platelet Rich Plasma Market by Application
 6.1 Platelet Rich Plasma Market Snapshot and Growth Engine
 6.2 Platelet Rich Plasma Market Overview
 6.3 surgery
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 surgery: Geographic Segmentation Analysis
 6.4 cosmetic surgery
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 cosmetic surgery: Geographic Segmentation Analysis
 6.5 general surgery
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 general surgery: Geographic Segmentation Analysis
 6.6 neurosurgery
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 neurosurgery: Geographic Segmentation Analysis
 6.7 other surgeries
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 other surgeries: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Platelet Rich Plasma Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 AESTHETICS BIOMEDICAL
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ARTHREX
 7.4 CELLERATION
 7.5 CELLTEX THERAPEUTICS
 7.6 CYTOMEDIX
 7.7 EMCYTE CORPORATION
 7.8 HARVEST TECHNOLOGIES
 7.9 HYALURONIC ACID CO
 7.10 KGEN BIOPHARMA
 7.11 PHOENIX BIOTECHNOLOGY
 7.12 PLASMAGE
 7.13 REGEN LAB
 7.14 REGENERATIVE MEDICAL SOLUTIONS
 7.15 SUNEVA MEDICAL
 7.16 TERUMO BCT
 7.17 OTHER KEY PLAYERS

Chapter 8: Global Platelet Rich Plasma Market By Region
 8.1 Overview
 8.2. North America Platelet Rich Plasma Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 pure-platelet-rich plasma (P-PRP)
  8.2.4.2 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF)
  8.2.5 Historic and Forecasted Market Size By Origin Type
  8.2.5.1 autologous
  8.2.5.2 homologous and allogenic
  8.2.6 Historic and Forecasted Market Size By Application
  8.2.6.1 surgery
  8.2.6.2 cosmetic surgery
  8.2.6.3 general surgery
  8.2.6.4 neurosurgery
  8.2.6.5 other surgeries
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Platelet Rich Plasma Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 pure-platelet-rich plasma (P-PRP)
  8.3.4.2 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF)
  8.3.5 Historic and Forecasted Market Size By Origin Type
  8.3.5.1 autologous
  8.3.5.2 homologous and allogenic
  8.3.6 Historic and Forecasted Market Size By Application
  8.3.6.1 surgery
  8.3.6.2 cosmetic surgery
  8.3.6.3 general surgery
  8.3.6.4 neurosurgery
  8.3.6.5 other surgeries
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Platelet Rich Plasma Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 pure-platelet-rich plasma (P-PRP)
  8.4.4.2 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF)
  8.4.5 Historic and Forecasted Market Size By Origin Type
  8.4.5.1 autologous
  8.4.5.2 homologous and allogenic
  8.4.6 Historic and Forecasted Market Size By Application
  8.4.6.1 surgery
  8.4.6.2 cosmetic surgery
  8.4.6.3 general surgery
  8.4.6.4 neurosurgery
  8.4.6.5 other surgeries
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Platelet Rich Plasma Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 pure-platelet-rich plasma (P-PRP)
  8.5.4.2 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF)
  8.5.5 Historic and Forecasted Market Size By Origin Type
  8.5.5.1 autologous
  8.5.5.2 homologous and allogenic
  8.5.6 Historic and Forecasted Market Size By Application
  8.5.6.1 surgery
  8.5.6.2 cosmetic surgery
  8.5.6.3 general surgery
  8.5.6.4 neurosurgery
  8.5.6.5 other surgeries
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Platelet Rich Plasma Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 pure-platelet-rich plasma (P-PRP)
  8.6.4.2 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF)
  8.6.5 Historic and Forecasted Market Size By Origin Type
  8.6.5.1 autologous
  8.6.5.2 homologous and allogenic
  8.6.6 Historic and Forecasted Market Size By Application
  8.6.6.1 surgery
  8.6.6.2 cosmetic surgery
  8.6.6.3 general surgery
  8.6.6.4 neurosurgery
  8.6.6.5 other surgeries
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Platelet Rich Plasma Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 pure-platelet-rich plasma (P-PRP)
  8.7.4.2 leukocyte-platelet-rich plasma (L-PRP) and leukocyte-platelet-rich fibrin (L-PRF)
  8.7.5 Historic and Forecasted Market Size By Origin Type
  8.7.5.1 autologous
  8.7.5.2 homologous and allogenic
  8.7.6 Historic and Forecasted Market Size By Application
  8.7.6.1 surgery
  8.7.6.2 cosmetic surgery
  8.7.6.3 general surgery
  8.7.6.4 neurosurgery
  8.7.6.5 other surgeries
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research